 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
UP FRONT
EVToday News
Chief Medical Editor's Page
Insights for 2004
By Takao Ohki, MD, PhD
VESSEL UPDATE
The CARESS Trial
This groundbreaking study sponsored by the International Society for Endovascular Specialists (ISES) involving collaboration among industry, the FDA, and CMS, is the first to address a broad range of symptomatic and asymptomatic carotid lesions.
By The ISES Steering Committee: Edward B. Diethrich, MD, Thomas Fogarty, MD, L. Nelson Hopkins, MD, Gary Roubin, MD, PhD, Rodney White, MD, (Chairman), Mark H. Wholey, MD, and Christopher Zarins, MD
CODING & REIMBURSEMENT
Principles of Endovascular Coding
What you don’t know about coding is just as important as what you do know.
By Katharine L. Krol, MD
CORONARY/CARDIAC INTERVENTIONS
Insights From The Portland DES Symposium
Part I: Treating complex coronary bifurcation lesions in the era of the drug-eluting stent requires careful planning and a strong knowledge base of the technology, components, and techniques.By Andrew J. Carter, DO, on behalf of the faculty
members
COVER STORY
Introduction/Stents from the Past, Present, and Future
To appreciate the potential of stenting, we must first understand the biological processes required for them to function properly.
By Julio C. Palmaz, MD
Update on Devices for Endovascular Therapy of AAAs
The Miami Cardiac & Vascular Interventional experience with today’s AAA devices.
By Barry T. Katzen, MD
Endovascular Repair of Ruptured AAAs
In treating AAAs, endovascular repair may hold the key over open repair to lowering mortality.
By Takao Ohki, MD, PhD, and Frank J. Veith, MD
SFA Stenting Update: The VALIANT Trial
Interventions of the superficial femoral artery continue to present difficulty, but the results of the VALIANT trial will evaluate whether this new technology is up to the challenge.
By Gary M. Ansel, MD, and Krishna Rocha-Singh, MD
The Cardiologist and Surgeon Relationship
What is the ideal arrangement for both practices and patient care?
By Craig M. Walker, MD, FACC
DEPARTMENTS
FDA Insights: What to Expect When You Are Inspected
Dorothy asks a former FDA Compliance Officer and Investigator about what you can expect when the FDA comes for a visit.
By Dorothy B. Abel
Drug-Eluting Stent Update (PDF)
An interview with John Abele, MD
As Boston Scientific begins its 25th year, its founder recalls the early days of minimally invasive therapy and shares his perspectives on the future.
